ZSFG Medicine Grand Rounds - MGR 22028

Ayesha Appa, MD

Clinical Fellow, Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco

Learning Objectives: 

1. Understand changing epidemiology of opioid and stimulant use since 2020
2. List 3 ways opioid use disorder management (buprenorphine, methadone) has changed in the last year
3. Identify an emerging adulterant drug to the opioid supply

Disclosure: Planners Raphaela Degette-Lipinsky, MD; Elizabeth Harleman, MD; Melody Davenport-McLaughlin, BA, and Evelina Azarian, BA have stated they have no financial relationships to disclose. Speaker Ayesha Appa, MD has no financial relationships to disclose.

Accreditation: The University of California, San Francisco School of Medicine (UCSF) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.  

Designation: UCSF designates this live activity for a maximum of 64 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The above credit is inclusive of all Fiscal year 2022 SFGH Medicine Grand rounds sessions.  You must sign in to Qualtrics to qualify for CME credit.

Zoom Information

http://tiny.ucsf.edu/DOMGrandRounds

Meeting ID: 968 1679 7792
Password: 1001
Call-in: +1 669 900 6833, +1 213 338 8477, +1 669 219 259

This presentation will be recorded and is accessible through My Access

https://lecture.ucsf.edu/ets/Catalog/Full/ab21c2921423425398199ec7e0720d6a2